NO141160C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamiderInfo
- Publication number
- NO141160C NO141160C NO742679A NO742679A NO141160C NO 141160 C NO141160 C NO 141160C NO 742679 A NO742679 A NO 742679A NO 742679 A NO742679 A NO 742679A NO 141160 C NO141160 C NO 141160C
- Authority
- NO
- Norway
- Prior art keywords
- isokinolinkarboxamides
- dihydro
- preparation
- therapeutic activity
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/52—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US381505A US3905982A (en) | 1973-07-23 | 1973-07-23 | 1-Aryl-n-dialkylaminoalkyl-3,4-dihydro-2(1H)-isoquinolinecarboxamides and related compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO742679L NO742679L (sv) | 1975-01-24 |
| NO141160B NO141160B (no) | 1979-10-15 |
| NO141160C true NO141160C (no) | 1980-01-23 |
Family
ID=23505299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO742679A NO141160C (no) | 1973-07-23 | 1974-07-22 | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3905982A (sv) |
| JP (1) | JPS5041873A (sv) |
| AR (2) | AR202416A1 (sv) |
| AT (1) | AT329563B (sv) |
| BE (1) | BE817917A (sv) |
| CA (1) | CA1041501A (sv) |
| CH (2) | CH605773A5 (sv) |
| DE (1) | DE2435168A1 (sv) |
| DK (1) | DK138644B (sv) |
| ES (2) | ES428503A1 (sv) |
| FR (1) | FR2238488B1 (sv) |
| GB (1) | GB1452398A (sv) |
| IE (1) | IE39630B1 (sv) |
| NL (1) | NL7409881A (sv) |
| NO (1) | NO141160C (sv) |
| SE (1) | SE387341B (sv) |
| ZA (1) | ZA744665B (sv) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8518634D0 (en) * | 1985-07-23 | 1985-08-29 | Smithkline Beckman Corp | Chemical compounds |
| DK8386A (da) * | 1986-01-15 | 1987-07-09 | Tpo Pharmachim | Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme |
| JP2577215B2 (ja) * | 1987-01-16 | 1997-01-29 | 化研生薬株式会社 | ベンジルイソキノリン誘導体 |
| US6376670B1 (en) | 1997-06-19 | 2002-04-23 | Sepracor Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| KR20010014030A (ko) | 1997-06-19 | 2001-02-26 | 더글라스이.리디치 | 퀴놀린-인돌 항균제, 이들의 용도 및 조성물 |
| US6207679B1 (en) | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
| US6858147B2 (en) * | 2001-08-03 | 2005-02-22 | Dispersion Technology, Inc. | Method for the removal of heavy metals from aqueous solution by means of silica as an adsorbent in counter-flow selective dialysis |
| US20060229524A1 (en) * | 2005-04-08 | 2006-10-12 | Alden Ozment | Method for the accurate placement of EKG electrodes |
| EP3763711A1 (en) * | 2019-07-09 | 2021-01-13 | Allinky Biopharma | Tetrahydroisoquinoline compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3524858A (en) * | 1967-05-18 | 1970-08-18 | Warner Lambert Pharmaceutical | 1,4 - dihydro-1-substituted alkyl-6,7-methylenedioxy - 4 - oxoquinoline-3-carboxylic acid |
| US3483206A (en) * | 1967-12-15 | 1969-12-09 | Ciba Geigy Corp | N-isoquinolylalkanoyl-n-arylamines |
| US3634429A (en) * | 1969-09-30 | 1972-01-11 | Hoffmann La Roche | Morphinan derivatives and preparation thereof |
| US3666763A (en) * | 1970-01-06 | 1972-05-30 | Hoffmann La Roche | 4-phenyl isoquinolines and process for preparing same |
-
1973
- 1973-07-23 US US381505A patent/US3905982A/en not_active Expired - Lifetime
-
1974
- 1974-07-19 GB GB3217874A patent/GB1452398A/en not_active Expired
- 1974-07-22 IE IE1546/74A patent/IE39630B1/xx unknown
- 1974-07-22 NO NO742679A patent/NO141160C/no unknown
- 1974-07-22 AR AR254830A patent/AR202416A1/es active
- 1974-07-22 BE BE146789A patent/BE817917A/xx unknown
- 1974-07-22 ZA ZA00744665A patent/ZA744665B/xx unknown
- 1974-07-22 CA CA205,331A patent/CA1041501A/en not_active Expired
- 1974-07-22 SE SE7409496A patent/SE387341B/sv unknown
- 1974-07-22 ES ES428503A patent/ES428503A1/es not_active Expired
- 1974-07-22 DE DE2435168A patent/DE2435168A1/de not_active Withdrawn
- 1974-07-22 AT AT602874A patent/AT329563B/de not_active IP Right Cessation
- 1974-07-22 NL NL7409881A patent/NL7409881A/xx not_active Application Discontinuation
- 1974-07-22 JP JP49084056A patent/JPS5041873A/ja active Pending
- 1974-07-22 DK DK395174AA patent/DK138644B/da unknown
- 1974-07-22 FR FR7425375A patent/FR2238488B1/fr not_active Expired
- 1974-07-23 CH CH1014974A patent/CH605773A5/xx not_active IP Right Cessation
- 1974-07-23 CH CH1394177A patent/CH605774A5/xx not_active IP Right Cessation
-
1975
- 1975-01-01 AR AR258939A patent/AR205380A1/es active
-
1976
- 1976-06-16 ES ES448973A patent/ES448973A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AR202416A1 (es) | 1975-06-06 |
| SE7409496L (sv) | 1975-01-24 |
| AR205380A1 (es) | 1976-04-30 |
| CA1041501A (en) | 1978-10-31 |
| JPS5041873A (sv) | 1975-04-16 |
| SE387341B (sv) | 1976-09-06 |
| CH605773A5 (sv) | 1978-10-13 |
| AT329563B (de) | 1976-05-25 |
| ES428503A1 (es) | 1976-12-16 |
| DK138644C (sv) | 1979-03-19 |
| GB1452398A (en) | 1976-10-13 |
| IE39630L (en) | 1975-01-23 |
| BE817917A (fr) | 1975-01-22 |
| DK138644B (da) | 1978-10-09 |
| US3905982A (en) | 1975-09-16 |
| DE2435168A1 (de) | 1975-02-06 |
| AU7147074A (en) | 1976-01-22 |
| FR2238488B1 (sv) | 1978-06-30 |
| NO141160B (no) | 1979-10-15 |
| ZA744665B (en) | 1975-09-24 |
| FR2238488A1 (sv) | 1975-02-21 |
| ES448973A1 (es) | 1977-11-16 |
| NO742679L (sv) | 1975-01-24 |
| IE39630B1 (en) | 1978-11-22 |
| CH605774A5 (sv) | 1978-10-13 |
| DK395174A (sv) | 1975-03-10 |
| ATA602874A (de) | 1975-08-15 |
| NL7409881A (nl) | 1975-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO143218C (no) | Analogifremgangsmaate til fremstilling av nonapeptidamider med lh-rh aktivitet | |
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO142304C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater | |
| NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
| NO142173C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater | |
| SE7710600L (sv) | Forfarande for framstellning av 1,3-bensoxazoler | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| NO146396C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO143223C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner | |
| NO148375C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser | |
| NO142303C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| NO141160C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider | |
| NO141755C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| FI55659C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 3-(4-substituerad-piperazin-1-ylkarbonyloxi)-2-(1,8-naftyridin-2-yl)isoindolin-1-oner | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO148376C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| NO141441C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on | |
| NO142669C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser | |
| NO150281C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater | |
| NO741929L (no) | Analogifremgangsmåte til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet. | |
| NO143845C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-amino-pyrrolderivater | |
| NO144488C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater |